October 30, 2014

DexCom Announces Upcoming Conference Presentations

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:

  • Steve Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Stephens 2014 Fall Investment Conference in New York, New York on Tuesday, November 11, 2014 at 11:00am (EST). The presentation, which will occur live at The New York Palace Hotel, will be concurrently webcast.
  • Kevin Sayer, President and Chief Operating Officer, will present an update on the company at 2014 Credit Suisse Healthcare Conference in Phoenix, Arizona on Wednesday, November 12, 2014 at 3:00pm (MST). The presentation, which will occur live at The Arizona Biltmore, will be concurrently webcast.

The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to "Our Company," then "Investor Relations," and finally "Events and Webcasts" and will be archived there for future reference.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

Cautionary Statement Regarding Forward Looking Statements

DexCom is a medical device company with a limited operating history. Successful commercialization of the company's products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the company's development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the company's quarterly report on Form 10-Q for the quarter ended June 30, 2014, as filed with the Securities and Exchange Commission on August 6, 2014.

DexCom, Inc.
Steven R. Pacelli, 858-200-0200
Executive Vice President, Strategy and Corporate Development

Source: DexCom, Inc.

News Provided by Acquire Media


Close window | Back to top

Copyright 2017 DexCom